Navigation Links
Palatin Technologies Receives Non-Compliance Letter from NYSE Amex
Date:12/2/2010

of peptide, peptide mimetic and small molecule agonists with a focus on melanocortin and natriuretic peptide receptor systems. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential.  For additional information regarding Palatin, please visit Palatin Technologies' website at www.palatin.com.

Forward-looking Statements

Statements in this press release that are not historical facts, including statements about meeting continued listing standards, plans of compliance relating to regaining compliance with listing standards, future financings and other future expectations of Palatin Technologies, Inc., are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 and as that term is defined in the Private Securities Litigation Reform Act of 1995. Palatin intends that such forward-looking statements be subject to the safe harbors created thereby. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause Palatin's actual results to be materially different from its historical results or from any results expressed or implied by such forward-looking statements.  Palatin's actual results may differ materially from those discussed in the forward-looking statements for reasons including, but not limited to, availability of financing on acceptable terms, results of clinical trials, regulatory actions by the FDA and the need for regulatory approvals, Palatin's ability to fund development of its technology and establish and successfully complete clinical trials, the length of time and cost required to complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, com
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
2. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
3. Palatin Technologies Initiates Phase 2 Hypertension Clinical Study With PL-3994
4. Palatin Technologies Presents PL-3994 Clinical Trial Results at the 12th Annual Scientific Meeting of the Heart Failure Association of America
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men
7. Palatin Technologies, Inc. To Raise $2.6 Million Dollars in Registered Direct Offering
8. Palatin Technologies, Inc. Receives $2.5 Million from AstraZeneca
9. Palatin Technologies, Inc. Announces Positive Safety Results in Subcutaneous Bremelanotide Trial in Men
10. Palatin Technologies to Present at Rodman & Renshaw Annual Global Investment Conference
11. Palatin Technologies to Present at 9th Annual BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 5, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... announced today that it will release its full financial results ... May 11 th before the open, followed by a ... results and business outlook. Participants should call (888) ... (International) and request the InspireMD call. A live webcast of ...
(Date:5/5/2015)... , May 5, 2015 GW Pharmaceuticals ... "Company"), a biopharmaceutical company focused on discovering, developing ... product platform, announced today the closing of the ... by GW of 1,600,000 American Depositary Shares (ADSs) ... gross proceeds of approximately $179.2 million (before deducting ...
(Date:5/5/2015)... , May 5, 2015 /CNW Telbec/ - ... Laval and known under the « ... the closing of the transaction previously announced on April ... issued and outstanding  shares of Orthoconcept (2008) inc.   ... 500 000 common shares (TSXV: ERG) to the vending ...
Breaking Medicine Technology:InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3
... Associated Foot & Ankle Specialists,today announced it ... diabetes,to participate in the MATRIX clinical trial. The ... Excellarate, for the potential treatment of,patients with non-healing ... to stimulate the process of wound healing., ...
... to Healthcare Market, ORLANDO, Fla., Feb. ... (NYSE: HRS ), an international communications ... Cancer Treatment,Services International (CTSI) to advance the ... provide advanced imaging and information,systems that assure ...
Cached Medicine Technology:Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment 2
(Date:5/6/2015)... 2015 The beverage industry has grocery ... Miracles organic tea and superfruit fusions stands out among ... sweetened with agave, these delicious juice blends are making ... healthier ways to hydrate. , In collaboration with National ... to raise a bottle of Lemongrass Tea and Ginseng, ...
(Date:5/5/2015)... With ProPoint: Hand Drawn, users can point, underline, ... X . With ProPoint: Hand Drawn, users can also ... customize each preset all with a click of a mouse. ... fully customizable effect presets all within Final Cut Pro X. ... underlines, and more. , ProPoint: Hand Drawn on-screen controls ...
(Date:5/5/2015)... May 05, 2015 Private equity consultant ... LLC has announced that its dental stem cell biobank ... increased once again--in April, 2015 –and posted yet another ... increased record volume and represents a significant 54% increase ... stem cell biobank is conducted via the Store-A-Tooth brand. ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Carlini CPA, ... Trail, Monroe, Matthews, Charlotte and surrounding areas. The company ... of accounting. This company provides assistance in making informed ... they prepare individual or corporate tax returns for their ... the cloud that allows clients (and Carlini CPA) to ...
(Date:5/5/2015)... AxoGen, Inc. (NASDAQ: AXGN), a ... peripheral nerve repair market, reported record revenue of $4.95 ... compared to $3.14 million in the year-ago first quarter. ... portfolio of nerve repair products - Avance® Nerve ... and our solid sales execution delivered another record quarter ...
Breaking Medicine News(10 mins):Health News:Say Cheers to National Beverage Day with Little Miracles 2Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4
... Q2 2007 Levels, - STAAR Announces Internet Marketing Campaign with ... ... MONROVIA, Calif., June 12 STAAR Surgical,Company (Nasdaq: STAA ), a ... Visian ICL(TM),(Implantable Collamer Lens) sales in the U.S. for the second quarter ...
... for Model Evaluation; Dr. Mike Dunlavey Will Present Simplified ... ... June 12 Pharsight,Corporation (Nasdaq: PHST ), a leading ... drug,development, today announced that Pharsight software development experts,will deliver two ...
... time is associated with overweight in children and adolescents, ... reduced REM sleep, according to a research abstract that ... 22nd Annual Meeting of the Associated Professional Sleep Societies ... PhD, of the University of Pittsburgh, focused on 335 ...
... has announced that it has,been awarded the prestigious Emerging ... Wound Management category., KFH,s CEO, Henk Snyman, MD, ... respected company such as Frost & Sullivan. We have,achieved ... to create,a continuous stream of state-of-the-art, portable medical devices ...
... Mich. A type of stroke that can strike at ... be more common in women and Mexican-Americans than in non-Hispanic ... of Michigan Stroke Program. , In a paper published online ... report that women had a 74 percent greater chance of ...
... GROVE, Ill., June 11 Lifeway Foods,Inc., (Nasdaq: ... kefir, announced today that they are now using milk ... certified hormone free milk comes,with a Farmers Pledge, which ... change came as a response to a growing demand ...
Cached Medicine News:Health News:STAAR Surgical's LASIK Alternative Expands U.S. Market Gains 2Health News:STAAR Surgical's LASIK Alternative Expands U.S. Market Gains 3Health News:STAAR Surgical's LASIK Alternative Expands U.S. Market Gains 4Health News:Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting 2Health News:Pharsight to Present on Its Vision for Modeling and Simulation Software at PAGE Annual Meeting 3Health News:REM sleep associated with overweight in children and adolescents 2Health News:REM sleep associated with overweight in children and adolescents 3Health News:Kingfisher Healthcare (KFH) Wins Prestigious Frost & Sullivan Best Practices Award 2Health News:Women, Mexican-Americans at higher risk of ruptured brain aneurysm 2Health News:Women, Mexican-Americans at higher risk of ruptured brain aneurysm 3Health News:Lifeway Foods Switches to 100% Certified Hormone Free Milk 2
Colloidal Gold Sol, 20 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
CranioFix2 is the next generation CranioFix Titanium Clamp System, which is up to 40% faster than the original CranioFix and all flap fixation systems on the market....
... P-2000 FastPach is an accurate, reliable, ... glaucoma screenings. It works off of ... charging of the device a breeze. ... controls make operating and viewing results ...
... PalmScan A2000] device is intended as a ... ultrasound,technology, and thus may be used to ... depth (ACD), and lens thickness (LT) of ... intended for calculating the optical power of ...
Medicine Products: